SOLD
Hilco is delighted to offer for sale the business and assets of a pioneering UK-based technology company specialising in implantable biosensors and wearable motion capture solutions for animal health applications (the “Company”).
Leveraging deep expertise in movement tracking, biomarker monitoring, and AI-driven data analytics, the Company has developed a suite of innovative technologies, including a proprietary implantable microchip designed to read internal biomarkers in real time to provide continuous health and behavioural insights across a wide range of animal species. These technologies are engineered to support early diagnosis, condition monitoring, and preventative care for both companion animals and livestock.
The Company’s proprietary platform combines advanced motion capture with physiological monitoring to deliver precision data for use in veterinary, pharmaceutical, insurance, and agri-tech applications. Developed in collaboration with industry stakeholders, the technology has demonstrated strong commercial potential and is primed for scale.
This opportunity presents a compelling chance for an acquirer to capitalise on a scalable, IP-rich platform at the forefront of the rapidly expanding animal health and precision livestock management markets.
Business Highlights:
All expressions of interest and bids are to be directed to Hilco in writing. A Bid Submission Form is available on request. Please contact Hilco to gain access to a virtual data room of further information on signing a confidentiality agreement.
Hilco is acting as exclusive agent to the Company and its Proposed Administrators in connection with the proposed sale of some or all of the Company’s assets. The Joint Administrators act as agents of the Company and without personal liability.
All sales are made strictly on an “as is, where is” basis. Only such right, title and interest (if any) as the Company may have in the assets will be transferred to a purchaser. No warranties, guarantees, or representations (express or implied) are provided by the Company, its Proposed Administrators or Hilco in respect of the assets or any information supplied. All parties must rely on their own enquiries and due diligence. Any information provided is for convenience only and has not been independently verified.
All offers are subject to the addition of VAT at the prevailing rate, where applicable. A non-refundable deposit equal to 20% of the agreed purchase price must be paid by the successful purchaser within 48 hours of offer acceptance. Payment of the deposit grants the purchaser the exclusive right to proceed with the acquisition of the relevant assets for a limited period and on the terms agreed. A Buyer’s Premium of 10% of the final purchase price is payable by the successful purchaser in addition to the agreed purchase price, is non-negotiable and is payable at the same time and in the same manner as the purchase price and forms a condition of sale.
Legal completion must occur within five (5) business days of offer acceptance, unless otherwise agreed in writing by the Company and its Proposed Administrators.
